Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristian Loretelli

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
The International Journal of Biological Markers|June 26, 2015
HER family receptor expression and prognosis in pancreatic cancerAlessandro Bittoni, Alessandra Mandolesi, Kalliopi Andrikou, et al.
European Journal of Human Genetics : EJHG|May 26, 2006
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional featuresLaura Belvederesi, Francesca Bianchi, Cristian Loretelli, et al.
Familial Cancer|December 14, 2006
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-ItalyFrancesca Bianchi, Eva Galizia, Emilio Porfiri, et al.
Pharmacogenomics|October 5, 2013
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patientsMario Scartozzi, Riccardo Giampieri, Cristian Loretelli, et al.
Future Oncology (London, England)|July 11, 2015
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinomaAlessandro Bittoni, Francesco Piva, Matteo Santoni, et al.
Plos One|March 31, 2012
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical managementMario Scartozzi, Luca Faloppi, Maristella Bianconi, et al.
Oncotarget|May 14, 2016
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinomaMaristella Bianconi, Luca Faloppi, Cristian Loretelli, et al.
Journal of Translational Medicine|May 7, 2015
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximabRiccardo Giampieri, Alessandra Mandolesi, Khaled M Abouelkhair, et al.
Journal of Diabetes and Metabolic Disorders|November 29, 2024
A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitusAntonio Rossi, Giada Rossi, Laura Montefusco, et al.
Future Oncology (London, England)|April 27, 2013
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximabMario Scartozzi, Riccardo Giampieri, Cristian Loretelli, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
The International Journal of Biological Markers|June 26, 2015
HER family receptor expression and prognosis in pancreatic cancerAlessandro Bittoni, Alessandra Mandolesi, Kalliopi Andrikou, et al.
European Journal of Human Genetics : EJHG|May 26, 2006
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional featuresLaura Belvederesi, Francesca Bianchi, Cristian Loretelli, et al.
Familial Cancer|December 14, 2006
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-ItalyFrancesca Bianchi, Eva Galizia, Emilio Porfiri, et al.
Pharmacogenomics|October 5, 2013
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patientsMario Scartozzi, Riccardo Giampieri, Cristian Loretelli, et al.
Future Oncology (London, England)|July 11, 2015
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinomaAlessandro Bittoni, Francesco Piva, Matteo Santoni, et al.
Plos One|March 31, 2012
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical managementMario Scartozzi, Luca Faloppi, Maristella Bianconi, et al.
Oncotarget|May 14, 2016
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinomaMaristella Bianconi, Luca Faloppi, Cristian Loretelli, et al.
Journal of Translational Medicine|May 7, 2015
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximabRiccardo Giampieri, Alessandra Mandolesi, Khaled M Abouelkhair, et al.
Journal of Diabetes and Metabolic Disorders|November 29, 2024
A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitusAntonio Rossi, Giada Rossi, Laura Montefusco, et al.
Future Oncology (London, England)|April 27, 2013
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximabMario Scartozzi, Riccardo Giampieri, Cristian Loretelli, et al.
Pageof 7